ArticleBMJ open2026
Theory-based dyadic co-learning intervention to enhance family resilience in men with prostate cancer and their spouses in Taiwan: protocol for a randomised controlled trial.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07196488 (Development and Exploring the Efficacy of a Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Development and Exploring the Efficacy of a Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe diagnosis and treatment of prostate cancer often disrupt patients' and their spouses' established family lives, requiring them to reestablish a sense of balance. This study aims to develop and evaluate a dyadic co-learning intervention derived from the activation-reinforcement-adjustment theory of family resilience for patients with prostate cancer and their spouses. METHODS AND ANALYSIS: An experimental study design was employed. Prostate cancer patients and their spouses (n=60 pairs) will be recruited from the outpatient department. Following baseline assessment, participants will be randomly assigned to either the intervention group or the control group (1:1). The intervention group receives an 8 week dyadic co-learning intervention and usual care, whereas the control group receives usual care. All participants complete follow-up assessments at 10 weeks and 16 weeks after the pretest. Structured questionnaires included the Resilience Scale, the Walsh Family Resilience Questionnaire, the Loneliness Scale, the Chinese Happiness Inventory, the Brief Fatigue Inventory and the Expanded Prostate Cancer Index Composite. Statistical analyses include independent-samples ETHICS AND DISSEMINATION: This study protocol was approved by the Chang Gung Medical Foundation Institutional Review Board (No. 202 202 198B0). The study findings will be disseminated through international conferences and publication in peer-reviewed journals. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov ID: NCT07196488 (First Submitted 2025-09-06).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.